Information Specification

The data items required for National Cancer Data Standards for Wales – Site Specific – Skin and their equivalent labels in COSD V9.0, where there is an equivalent, are listed below.

 

Where the specification cites NHS Wales Data Dictionary, please refer to the Dictionary for the relevant guidance i.e. definition, format, or code list.

 

For consistency, all dates listed in the Specification are standardised as ccyymmdd.

 

Where D is denoted in Status, this indicates that the information should be derived from another data item. This typically occurs with data items that are simply text representations of their code counterparts. Other Status codes are M (Mandatory), R (Required) – the data item should be recorded where applicable and O (Optional).

 

 

 

Core data items should be collected for all cancers.  To reduce replication of information, Core data items have not been listed in this site-specific Standard and users should refer to National Cancer Data Standards for Wales – (1. National Cancer Data Set - Full list DSCNs.xlsx (live.com) for a list of Core requirements. However, in some cases, the site-specific application of Core data items may differ e.g. a particular tumour site may require additional or fewer codes to those already published in Core, or perhaps have additional business rules as to how the Core data item should be coded. Where this occurs, the Core data item will be replicated in the site-specific Standard with the respective additional site-specific detail. These are flagged in the following table with an * next to the data item name.

 

 

For data items used in the National Cancer Data Standards for Wales that already exist within the NHS Wales Data Dictionary. These data items have been flagged with an next to the data item name, as whilst this introduces a change to an existing information standard, the immediate use of this mandate will be used as a framework for the development of the CIS, therefore service/data providers should continue with ‘business as usual’ in terms of the data being collected and reported.

 

 

 

 

National Cancer Data Standards for Wales – Skin

 

Melanoma

Every new melanoma (as per CWT) will require a Core and Skin site-specific completion. Where a patient has multiple surgeries for that melanoma they should be recorded as such.

 

Reporting Data Item

Definition

Format

Code List (Code)

Code List (Text)

Status

COSD

Skin – Clinical Examination – Malignant Melanoma.  To record staging of malignant melanoma of skin

Size of Tumour (Largest Diameter)

Record the size of the tumour (largest diameter) as determined by the Clinician after a physical examination. Measure in centimetres (cms)

max n2.n2

N/A

N/A

R

N/A

Date Draining Lymph Node Basins Examined

Record the date that relevant draining lymph node basins were clinically examined (palpated in clinic) before WLE. Where it has been documented that the patient has no regional disease, no lymphadenopathy, or no palpable lymph nodes then this is confirmation that relevant draining lymph node basins have been examined

ccyymmdd

N/A

N/A

R

N/A

Skin – Diagnostic Procedures – Malignant Melanoma.  To carry cancer diagnostic details for malignant melanoma of skin.  (Multiple occurrences per core diagnostic procedure group)

Grade of Clinician/Surgeon (Diagnostic Procedure)

This is the level of training reached of the actual  Clinician* or Surgeon performing the diagnostic procedure (excision or partial biopsy), and not necessarily the responsible clinician

Code List

NU

Nurse

R

N/A

TS

Trainee Specialist Doctor

CS

Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon )

CD

Consultant Dermatologist

CPS

Consultant Plastic Surgeon

ENT

Consultant ENT Surgeon

OMF

Oral Maxillofacial (OMF) Surgeon

HP

Hospital Practitioner/Specialty & Associate Specialist (SAS)

SI

GP with Special Interest

GP

General Practitioner

OO

Other Care Professional

Biopsy Type

Record the type of diagnostic biopsy that the patient has undergone

Code List

E

Excision Biopsy

R

N/A

P

Partial Biopsy

NB

No Biopsy

9

Not known

Skin – Treatment – Surgery and Other Procedures – Malignant Melanoma.  To carry additional surgery details for malignant melanoma of skin.  (One Occurrence per Surgical episode  - all data items within this section are required)

Grade of Clinician/Surgeon Operating

This is the level of training reached of the actual operating Clinician or Surgeon, and not necessarily the responsible clinician.

Note: Of the adjacent codes
(i) Consultant ENT Surgeon and  Oral Maxillofacial (OMF) Surgeon  are not present in COSD. These have been added here to provide greater granularity.
(ii) Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon ) and Hospital Practitioner/Specialty & Associate Specialist (SAS) contain additional text in the descriptor to those provided in COSD.

Code List

NU

Nurse

R

Grade of Clinician/Surgeon Operating  (SK12010)

TS

Trainee Specialist Doctor

CS

Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon )

CD

Consultant Dermatologist

CPS

Consultant Plastic Surgeon

ENT

Consultant ENT Surgeon

OMF

Oral Maxillofacial (OMF) Surgeon

HP

Hospital Practitioner/Specialty & Associate Specialist (SAS)

SI

GP with Special Interest

GP

General Practitioner

OO

Other Care Professional

Member of Specialist MDT

Is the actual operating Clinician or Surgeon a member of the Specialist MDT

Code List

Y

Yes

R

Member of Specialist MDT  (SK12700)

N

No

9

Not known

Depth of Excision

At the time of definitive surgery, record the extent of the deep excision margin in terms of tissue layers.

Note: This should be recorded by the operating surgeon on the operation notes or in the clinical notes relating to the specimen from the final definitive surgery.
This will be confirmed later by microscopic examination and the result can be found on the pathology report.

Code List

1

Less than deep fascia

R

N/A

2

Down to deep fascia

8

Not applicable

9

Not recorded

Smallest Clinical Margin of Excision

At the time of definitive surgery, record the smallest clinically measured and documented distance to the edge of the visible component of the excision scar/tumour from the resection margin (in centimetres)

Note: For patients that do not have further surgery following their diagnostic excision biopsy, record as Not applicable

Code List

1

<1cm

R

N/A

2

1- <2cm

3

2- <3cm

4

>/= 3cm

8

Not applicable

9

Not recorded

Clinical Margin

Record the clinical margin at the time of excisional bx prior to WLE (in millimetres).

Note: This will be clinically measured and documented at the time of each surgical procedure and can be found on either the pathology report or surgical operation note.
For patients that do not have surgery or full excision not performed (sample biopsy), record as Not applicable

Code List

1

<2mm

R

N/A

2

2mm

3

>2mm

8

Not applicable

9

Not recorded

Skin – MDT – Malignant Melanoma.  To carry additional MDT details for malignant melanoma of skin

Tumour Resectable

Record the decision made in MDT meeting on whether the tumour is resectable or not.

Note: Unresectable melanoma is such that all sites of melanoma tumours cannot be completely removed surgically. It should be documented in MDT summary and should not be deduced. Where the origin of the primary lesion is not identifiable this would be classed as unresectable

Code List

Y

Yes- resectable

R

N/A

N

No – unresectable

8

Not applicable

9

Not recorded

Skin – Treatment – Further Surgery and Other Procedures – Malignant Melanoma

Wide Local Excision

Has the patient undergone a wide local excision of the initial diagnostic biopsy site

Code List

Y

Yes

R

N/A

N

No

8

Not applicable

9

Not known/not recorded

Pathology – Malignant Melanoma.  To carry pathology details for malignant melanoma of skin.  (One occurrence per Path Report)

Skin Cancer Lesion Indicator

This is the specimen number or letter used to identify the specimen within a report. Where more than one primary skin cancer is reported on the same pathology report, record the lesion number or letter as specified on the pathology report.

Max an3

N/A

N/A

R

Skin Cancer Lesion Indicator  (pSK12120)

Ulceration Indicator

Loss of full thickness of epidermis associated with reactive changes (ulceration)

Code List

Y

Yes

R

Ulceration Indicator (pSK12580)

N

No 

U

Uncertain

X

Cannot be assessed

9

Not Known

Mitotic Rate (Skin)

Mitotic Rate per square millimetres (mm)

max n3

N/A

N/A

R

Mitotic Rate (Skin) (pSK12590)

Microsatellite or In-transit Metastasis Indicator

Is there evidence of Microsatellite or in transit metastases
(Intralymphatic metastatic cells separate from main tumour)

Code List

Y

Yes 

R

Microsatellite or In-transit Metastasis Indicator (pSK12600)

N

No 

U

Uncertain

X

Cannot be assessed

9

Not Known

Tumour Regression Indicator

Area of loss of tumour associated with reactive changes

Code List

Y

Yes 

R

Tumour Regression Indicator (pSK12620)

N

No 

U

Uncertain

X

Cannot be assessed

9

Not Known

Breslow Thickness

Breslow Thickness in mm, can be recorded to nearest 0.01mm where clinically appropriate

max n2.max n2

N/A

N/A

R

Breslow Thickness (pSK12630)

Tumour Infiltrating Lymphocytes (TILS)

Type of TILS. Tumour infiltrating lymphocytes (TILS) are white blood cells that have left the bloodstream and migrated into a tumour

Code List

N

Non-brisk

R

Tumour Infiltrating Lymphocytes (TILS) (pSK12430)

B

Brisk

A

Absent

Sentinel Nodes Examined Number

Number of sentinel nodes sampled

max n2

N/A

N/A

R

Sentinel Nodes Examined Number (pSK12460)

Sentinel Nodes Positive Number

Number of sentinel nodes positive

max n2

N/A

N/A

R

Sentinel Nodes Positive Number (pSK12470)

Post SNB Completion Lymphadenectomy – Nodes Sampled Number

Post Sentinel Node Biopsy (SNB) completion lymphadenectomy, number of nodes sampled.
This procedure is not carried out in all cases

max n2

N/A

N/A

R

Post SNB Completion Lymphadenectomy – Nodes Sampled Number (pSK12480)

Post SNB Completion Lymphadenectomy – Nodes Positive Number

Post Sentinel Node Biopsy (SNB) completion lymphadenectomy, number of nodes positive.
This procedure is not carried out in all cases

max n2

N/A

N/A

R

Post SNB Completion Lymphadenectomy – Nodes Positive Number (pSK12490)

Histopathology Report Complete

Record if all information required in the pathology report is complete. 

Note: Full information required as defined by the RCPath Cutaneous Malignant Melanoma Dataset (Please refer to User Guide for details)

Code List

1

Complete 

R

N/A

2

Not Complete

8

Not Applicable

9

Not Recorded

Skin – Molecular and Biomarkers – Somatic Testing for Targeted Therapy and Personalised Therapy – Malignant Melanoma

BRAF V600 mutation analysis of primary lesion, at diagnosis

Record the result of BRAF V600 mutation analysis of the primary lesion at the time of diagnosis

Code List

1

Positive

R

N/A

2

Negative

3

Indeterminate/Test Failed

8

Not Applicable (Not Tested)

9

Not Known

BRAF V600 mutation analysis of metastatic tissue

Record the result of BRAF V600 mutation analysis of metastatic tissue

Code List

1

Positive

R

N/A

2

Negative

3

Indeterminate/Test Failed

8

Not Applicable (Not Tested)

9

Not Known

 

 

Cutaneous Squamous Cell Carcinoma (cSCC)

Every new cSCC (as per CWT) will require a Core and Skin site-specific completion.

 

Reporting Data Item

Definition

Format

Code List (Code)

Code List (Text)

Status

COSD

Skin - Clinical Examination - Cutaneous Squamous Cell Carcinoma.  To record staging of cutaneous squamous cell carcinoma

Date Draining Lymph Node Basins Examined

Record the date that relevant draining lymph node basins were clinically examined (palpated in clinic) before standard surgical excision. Where it has been documented that the patient has no regional disease, no lymphadenopathy, or no palpable lymph nodes then this is confirmation that relevant draining lymph node basins have been examined

ccyymmdd

N/A

N/A

R

N/A

Skin - Treatment - Surgery and Other Procedures - Cutaneous Squamous Cell Carcinoma.  To carry additional surgery details for cSCC.  (One Occurrence per Surgical episode  - all data items within this section are required)

Grade of Clinician/Surgeon Operating

This is the level of training reached of the actual operating Clinician or Surgeon, and not necessarily the responsible clinician.

Note: Of the adjacent codes
(i) Consultant ENT Surgeon and  Oral Maxillofacial (OMF) Surgeon  are not present in COSD. These have been added here to provide greater granularity.
(ii) Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon ) and Hospital Practitioner/Specialty & Associate Specialist (SAS) contain additional text in the descriptor to those provided in COSD.

Code List

NU

Nurse

R

Grade of Clinician/Surgeon Operating  (SK12010)

TS

Trainee Specialist Doctor

CS

Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon )

CD

Consultant Dermatologist

CPS

Consultant Plastic Surgeon

ENT

Consultant ENT Surgeon

OMF

Oral Maxillofacial (OMF) Surgeon

HP

Hospital Practitioner/Specialty & Associate Specialist (SAS)

SI

GP with Special Interest

GP

General Practitioner

OO

Other Care Professional

Member of Specialist MDT

Is the actual operating Clinician or Surgeon a member of the Specialist MDT

Code List

Y

Yes

R

Member of Specialist MDT  (SK12700)

N

No

9

Not known

Smallest Clinical Margin of Excision

At the time of definitive surgery, record the smallest clinically measured and documented distance to the edge of the visible component of the excision scar/tumour from the resection margin (in centimetres)

Note: For patients that do not have further surgery following their diagnostic excision biopsy, record as Not applicable

Code List

1

<1cm

R

N/A

2

1- <2cm

3

2- <3cm

4

>/= 3cm

8

Not applicable

9

Not recorded

Skin - Diagnostic Procedures - Cutaneous Squamous Cell Carcinoma.  To carry cancer diagnostic and prognostic details for cutaneous squamous cell carcinoma

Risk Category

Record the assigned risk category of patients with primary cSCC

Code List

1

Low risk

R

N/A

2

High risk

3

Very high risk

9

Not known

Pathology - cSCC.  To carry pathology details for cutaneous Squamous Cell Carcinoma.  (One occurrence per Path Report)

Skin Cancer Lesion Indicator

This is the specimen number or letter used to identify the specimen within a report. Where more than one primary skin cancer is reported on the same pathology report, record the lesion number or letter as specified on the pathology report.

max an3

N/A

N/A

R

Skin Cancer Lesion Indicator  (pSK12120)

Perineural Invasion

Is there perineural invasion (invasion into perineurium of nerve bundles- PNI)

Code List

Y

Yes 

R

Perineural Invasion  (pSK12530)

N

No 

X

Cannot be assessed

9

Not Known

Lesion Diameter Greater than 20mm Indicator

Is the diameter of the lesion greater than 20mm?

Code List

Y

Yes (Greater than 20mm)

R

Lesion Diameter Greater than 20mm Indicator  (pSK12537)

N

(Less than or equal to 20mm)

U

Uncertain

X

Cannot be assessed

9

Not Known

Clarks Level IV Indicator

Greater than or equal to Clarks level IV

Code List

Y

Yes

R

Clarks Level IV Indicator  (pSK12545)

N

No

U

Uncertain

X

Cannot be assessed

Lesion Vertical Thickness Greater than 4mm Indicator

Is the vertical thickness of the lesion greater than 4 mm

Note:
(i) The name of the Data Item differs to that in COSD. This has been changed to align with BAD cSCC guidelines
(ii) Codes Yes (Greater than 4 mm) and No (Greater than 2 mm but less than or equal to 4 mm) have been introduced, and differ to COSD, to support the revised alignment
  

Code List

Y

Yes (Greater than 4 mm)

R

Lesion Vertical Thickness Greater than 2mm Indicator  (pSK12565)

N1

No (Less than or equal to 2 mm)

N2

No (Greater than 2 mm but less than or equal to 4 mm)

U

Uncertain

X

Cannot be assessed

9

Not Known

Histopathology Report Complete (cSCC)

Record if all information required in the pathology report is complete. 

Note: Full information required as defined by the RCPath Primary Invasive Cutaneous Squamous Cell Carcinoma Dataset (Please refer to User Guide for details)

Code List

1

Complete 

R

N/A

2

Not Complete

8

Not Applicable

9

Not Recorded

Skin - Post Treatment Follow Up - Cutaneous Squamous Cell Carcinoma

Follow Up Schedule

Record if the patient is scheduled to receive post treatment (surgical) follow up appropriate to their risk category

Please refer to the  User Guide for details of the follow up schedule for each risk category

Code List

Y

Yes

R

N/A

N

No

9

Not known/not recorded

 

 

Basal Cell Carcinoma (BCC)

Only the first BCC should be recorded. Any subsequent occurrences, irrespective of skin location, should be added to the original (first BCC).  Therefore, only one Core and Skin site-specific completion is required, however there may be multiple surgeries/paths included in that one completion to reflect subsequent lesions. 

 

Reporting Data Item

Definition

Format

Code List (Code)

Code List (Text)

Status

COSD

Skin - Diagnosis.  To carry additional tumour diagnosis details for Skin.  (Multiple occurrences per core diagnostic procedure group)

Skin - Diagnosis - Basal Cell Carcinoma

Anatomical Site of Lesion

This is the region of the body where the lesion is present

Code List

1

Peri-Ocular

R

N/A

2

Head and Neck

3

Trunk

4

Limbs

Skin - Treatment - Surgery and Other Procedures - Basal Cell Carcinoma.  To carry additional surgery details for BCC

Grade of Clinician/Surgeon Operating

This is the level of training reached of the actual operating Clinician or Surgeon, and not necessarily the responsible clinician.

Note: Of the adjacent codes
(i) Consultant ENT Surgeon and  Oral Maxillofacial (OMF) Surgeon  are not present in COSD. These have been added here to provide greater granularity.
(ii) Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon ) and Hospital Practitioner/Specialty & Associate Specialist (SAS) contain additional text in the descriptor to those provided in COSD.

Code List

NU

Nurse

R

Grade of Clinician/Surgeon Operating  (SK12010)

TS

Trainee Specialist Doctor

CS

Consultant Surgeon (other than Plastic Surgeon/ENT Surgeon/OMF Surgeon )

CD

Consultant Dermatologist

CPS

Consultant Plastic Surgeon

ENT

Consultant ENT Surgeon

OMF

Oral Maxillofacial (OMF) Surgeon

HP

Hospital Practitioner/Specialty & Associate Specialist (SAS)

SI

GP with Special Interest

GP

General Practitioner

OO

Other Care Professional

Member of Specialist MDT

Is the actual operating Clinician or Surgeon a member of the Specialist MDT

Code List

Y

Yes

R

Member of Specialist MDT  (SK12700)

N

No

9

Not known

Pathology - BCC.  To carry pathology details for Basal Cell Carcinoma.  (One occurrence per Path Report)

Skin Cancer lesion Indicator

This is the specimen number or letter used to identify the specimen within a report. Where more than one primary skin cancer is reported on the same pathology report, record the lesion number or letter as specified on the pathology report.

max an3

N/A

N/A

R

Skin Cancer Lesion Indicator  (pSK12120)

Perineural Invasion

Is there perineural invasion (invasion into perineurium of nerve bundles- PNI)

Code List

Y

Yes 

R

Perineural Invasion  (pSK12530)

N

No 

X

Cannot be assessed

9

Not Known

Lesion Diameter Greater than 20mm Indicator

Is the diameter of the lesion greater than 20mm?

Code List

Y

Yes (Greater than 20mm)

R

Lesion Diameter Greater than 20mm Indicator  (pSK12537)

N

(Less than or equal to 20mm)

U

Uncertain

X

Cannot be assessed

9

Not Known